Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae372ddaa494f2face39592b0429cc16 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-485 |
filingDate |
2013-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50608047928ec4e4faef2f536ca2a7a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d40da8461c7dbf5866d9dee7f5b0e282 |
publicationDate |
2015-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101531944-B1 |
titleOfInvention |
VEGF-BPB specifically binding to VEGF |
abstract |
The present invention provides a pharmaceutical composition for the prevention or treatment of angiogenesis-related diseases comprising VEGF-BPB specifically binding to VEGF, a nucleic acid molecule encoding the same, a recombinant vector comprising the nucleic acid molecule, and VEGF-BPB . The two distal VEGF-target binding sites that are bound at both ends of the structure stabilizing region in the VEGF-BPB of the present invention cooperatively cooperatively bind to the target synergetically to form VEGF- Induced angiogenesis. |
priorityDate |
2013-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |